Received Mar 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | — | IM / LL |
The patient inadvertently received Kinrix (DTaP-IPV), which is not approved for his age/dose, instead of DTaP. The patient did not have any adverse reaction to the vaccine and does not require treatment. The patient's parents have been notified of the administration error and report that the patient has not any adverse reactions. The dose does appear to count in the Registry towards the patient's DTaP and IPV series.
none reported
none reported
None
no known allergies
No testing has been required.